Goel`s view on Bajaj Auto, TVS Motor

Published on Tue, Jan 03, 2012 at 12:19 |  Source : CNBC-TV18

Updated at Tue, Jan 03, 2012 at 15:35  

23122 Investors following Bajaj Auto. Share this News with them.
0
0
Share on Tumblr
Hitesh Goel, Analyst, Kotak Institutional Equities

Excerpts from Bazaar on CNBC-TV18 Watch the full show ยป

ALSO READ

Hitesh Goel, Analyst, Kotak Institutional Equities shares his view on Bajaj Auto and TVS Motor .

Goel told CNBC-TV18, "We cover Hero Motocorp and Bajaj Auto, we prefer Bajaj Auto and Hero Motocorp, we have a sell rating on Hero Motocorp largely because we expect competition to increase in the 100 CC segment for Hero Motorcop. Whereas for Bajaj we prefer it because exports growth remains very strong. On domestic valuation definitely there will be a 4-5% downward revision in FY12 but I think still FY13 you could see 10-12% growth on the two-wheeler side because the crop output has been pretty good this year."

He further added, " TVS Motor on the motorcycle front they don't have much product profile to basically challenge the Honda and Hero of the world. I think they were doing well because of scooter portfolio and their popularity within the women segment. I think that could be challenge because Honda is looking at more launches on the scooter side next year which could impact TVS Motors more in my view and on the motorcycle side also they will be the first ones to loose markets side to Honda."

  

Trending News

Business News

2TB drives offer best value for money
Did Sebi miss any tricks in Ambani consent order? "Did Sebi miss any tricks in Ambani consent order?"

Oppn gears up to make Bharat bandh a success

On Facebook IPO Morgan Stanley Speculation Of 'Nefarious Activity' Around IPO Untrue

The latest earning numbers FIRST on CNBC-TV18
Videos

May 30 2012, 23:16

Clash of Spain and ECB worrying investors: Verstrate

- in FII View

May 30 2012, 11:18

Result corner: Ajay Bodke`s top bets from across sectors

- in MARKET OUTLOOK

Interviews

May 30 2012, 17:04 | Source: CNBC-TV18

Margins may be hit on one-off items in EBITDA: Sun Pharma  

May 30 2012, 16:32 | Source: CNBC-TV18

Essar announces Rs 175cr deal; to pay-off debts with fund  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!